Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Kirsty on +44 1494 818034 or kirstym@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Kirsty Morris
Senior Account Manager
kirstym@zenopa.com
+44 1494 818034

Testimonials
Your encouragement and support have been invaluable throughout the process, whether its in calming my increasingly frayed nerves, keeping my constantly up-to-date with developments.
Claire, 2011

CareFusion reports growth in 2012 fiscal year

10 August 2012 14:48 in Medical Company Financials


CareFusion has published encouraging financial results for the fourth quarter of its 2012 fiscal year, which ended on June 30th 2012.

The company's revenue total for the final three months of the business year came to $968 million (621.05 million pounds), up by three percent year over year, while income levels increased and expenses decreased over the same timeframe.

Medical system sales were driven up by record installations for infusion systems and double-digit sales increases for both respiratory and dispensing technologies, thus compensating for lower sales in the procedural solutions division.

This performance contributed to a $3.6 billion annual sales total for CareFusion, which was up by five percent compared to 2011.

Kieran Gallahue, the firm's chairman and chief executive officer, said: "I am proud of our team for the progress we made this year to optimise our portfolio, simplify the complexity of our infrastructure and reduce administrative expenses to fund research and development and other growth initiatives."

Earlier this year, the company agreed a deal to acquire UK Medical, a Sheffield-based distribution firm, which will aid its efforts to cement its success in the British market.ADNFCR-8000103-ID-801426595-ADNFCR

Other news stories from 10/08/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd